ArQule, Inc. Logo

Email this page: News Release

ArQule and Daiichi Sankyo Announce Discontinuation of Phase 3 MARQUEE Clinical Trial in Non-Small Cell Lung Cancer


Separate multiple addresses with commas. Maximum 200 characters.

These email addresses will be used to email the page on your behalf and will not be used by ArQule, Inc. for any marketing purposes.


This helps ArQule, Inc. prevent automated submissions.